NCT07141563 2026-01-07
A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
Bristol-Myers Squibb
Completed
Bristol-Myers Squibb
Pfizer
Hoffmann-La Roche
Hoffmann-La Roche
Qilu Pharmaceutical Co., Ltd.
GlaxoSmithKline
GlaxoSmithKline